Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| iBio, Inc.IBIO · Entity 6906 | President | June 04, 2020 | June 08, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
iBio, Inc.
Report date June 04, 2020 · Filed June 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,108 |
Reported balance
After 2020-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-06-04 · Exercise / conversion · Acquired 28,268 · Balance 108,108 F1: Reflects number of securities beneficially owned following all transactions reported on this Form 4. |
| Common StockSEC Table I · non-derivative | Direct | 108,108 |
Reported balance
After 2020-06-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-06-04 · Sale · Disposed 28,268 · Balance 108,108 F1: Reflects number of securities beneficially owned following all transactions reported on this Form 4. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2024-02-20 | Direct | 108,108 |
Reported balance
After 2020-06-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-06-04 · Exercise / conversion · Disposed 28,268 · Balance 108,108 F2: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of option grants to the reporting person in exchange for the options exercised in the transactions reported on this Form 4. F1: Reflects number of securities beneficially owned following all transactions reported on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects number of securities beneficially owned following all transactions reported on this Form 4.
F2: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of option grants to the reporting person in exchange for the options exercised in the transactions reported on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2020 Filed Jun 8, 2020 16:41 UTC | iBio, Inc. IBIO · Entity 6906 | Exercise / conversionStock Option (right to buy) · Derivative | 28,268 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-20-000582 · doc4_6747.xml · derivative · entry 3 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,108 Underlying: Common Stock · 28,268 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of option grants to the reporting person in exchange for the options exercised in the transactions reported on this Form 4. F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 16:41 UTC | iBio, Inc. IBIO · Entity 6906 | SaleCommon Stock | 28,268 | $1.71 | $48,338.28 |
DisclosureSEC source: 0001638599-20-000582 · doc4_6747.xml · nonDerivative · entry 2 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,108 F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 16:41 UTC | iBio, Inc. IBIO · Entity 6906 | Exercise / conversionCommon Stock | 28,268 | $0.93 | $26,289.24 |
DisclosureSEC source: 0001638599-20-000582 · doc4_6747.xml · nonDerivative · entry 1 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 10:04 UTC | iBio, Inc. IBIO · Entity 6906 | Exercise / conversionStock Option (right to buy) · Derivative | 96,124 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-20-000552 · doc4_6734.xml · derivative · entry 3 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,376 Underlying: Common Stock · 96,124 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 10:04 UTC | iBio, Inc. IBIO · Entity 6906 | SaleCommon Stock | 96,124 | $1.62 | $155,720.88 |
DisclosureSEC source: 0001638599-20-000552 · doc4_6734.xml · nonDerivative · entry 2 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,376 F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 10:04 UTC | iBio, Inc. IBIO · Entity 6906 | Exercise / conversionCommon Stock | 96,124 | $0.93 | $89,395.32 |
DisclosureSEC source: 0001638599-20-000552 · doc4_6734.xml · nonDerivative · entry 1 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 22,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 16 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 22,500 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 15 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 30,000 shares Expires 2027-05-01 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 56,250 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 14 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 56,250 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $17.20 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 13 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 75,000 shares Expires 2025-09-04 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 45,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 12 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 45,000 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $10.00 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 11 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 60,000 shares Expires 2024-09-05 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F7 · derivative.exercise_date: Vested in three equal annual instalments on the anniversary of the date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 22,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 10 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 22,500 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 9 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 30,000 shares Expires 2023-07-16 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 22,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 8 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 22,500 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 7 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 30,000 shares Expires 2022-07-24 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 22,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 6 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 22,500 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $19.60 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 5 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 30,000 shares Expires 2021-10-21 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 22,500 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 4 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 22,500 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $17.30 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 3 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 30,000 shares Expires 2019-08-16 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F5 · derivative.exercise_date: Vested 20% on 7/1/2010 and then in 20% instalments on each anniversary thereof. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 18,750 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 2 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 18,750 shares Expires 2024-02-20 F4 · price: On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. F3 · derivative.exercise_date: Fully vests on first anniversary of grant date. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| February 20, 2019 Filed May 13, 2019 15:33 UTC | iBio, Inc. IBIO · Entity 6906 | Disposition to issuerStock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001638599-19-000511 · doc4_6051.xml · derivative · entry 1 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,500 Underlying: Common Stock · 25,000 shares Expires 2019-08-10 F2 · price: On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. F1 · derivative.exercise_date: Vested in five annual instalments on anniversaries of date of grant. F6 · balance_after: Reflects number of securities beneficially owned following all transactions reported on this Form 4. Read SEC document |
| May 01, 2017 Filed Jun 16, 2017 15:14 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.40 Strike: $0.40 | $120,000.00 |
DisclosureSEC source: 0001638599-17-000611 · doc4_4801.xml · derivative · entry 1 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,350,000 Underlying: Common Stock · 300,000 shares Expires 2027-05-01 F1 · derivative.exercise_date: Vests in equal annual installments over three years beginning 12/1/16. Read SEC document |
| September 04, 2015 Filed Apr 5, 2017 21:08 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 750,000 | $1.72 Strike: $1.72 | $1,290,000.00 |
DisclosureSEC source: 0001638599-17-000355 · doc4_4656.xml · derivative · entry 2 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050,000 Underlying: Common Stock · 750,000 shares Expires 2025-09-04 F2 · derivative.exercise_date: (2) Vesting starts 7/1/2015, in equal annual installments over three years. Read SEC document |
| September 05, 2014 Filed Apr 5, 2017 21:08 UTC | iBio, Inc. IBIO · Entity 6906 | GrantStock Option (right to buy) · Derivative | 600,000 | $1.00 Strike: $1.00 | $600,000.00 |
DisclosureSEC source: 0001638599-17-000355 · doc4_4656.xml · derivative · entry 1 ERWIN ROBERT L · CIK 0001213822 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300,000 Underlying: Common Stock · 600,000 shares Expires 2024-09-05 F1 · derivative.exercise_date: (1) Vesting starts 7/1/2014, in equal annual installments over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.